Clinical trial
An Open-label Therapeutic Efficacy Study of Tirosint (Levothyroxine Sodium) Capsules in Thyroidectomized Patients Taking Proton Pump Inhibitors
NCT03094416 is registered in ClinicalTrials.gov with IBSA Institut Biochimique SA as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-label Therapeutic Efficacy Study of Tirosint (Levothyroxine Sodium) Capsules in Thyroidectomized Patients Taking Proton Pump Inhibitors
- Lead sponsor
- IBSA Institut Biochimique SA
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- July 30, 2018
- Completion date
- June 15, 2020
- Enrollment
- 66 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.
hypothyroidism;postablative